Return to search

Ansa Biotechnologies fetches $68m Series A

Ansa Biotechnologies, a provider of DNA synthesis service, has raised $68 million in Series A financing.

Ansa Biotechnologies, a provider of DNA synthesis service, has raised $68 million in Series A financing. Northpond Ventures led the round.

Source: Press Release